Skip to content
October 7, 2022
In the News
Seeking Alpha: Oramed oral COVID vaccine shows promise in phase 1 trial
Oramed oral COVID vaccine shows promise in phase 1 trial | Seeking Alpha
Prev
Previous
Fierce Biotech: Oramed phase 2 insulin drug data ‘paint an exciting picture’ in rocky NASH landscape
Next
Seeking Alpha: Oramed inks contract with Medicox to distribute oral insulin in South Korea
Next
You may also be interested
Times of Israel: Oramed inks huge $50m deal with Chinese pharma firm
December 22, 2015
In the News
Type 2: Oramed Sends Oral Insulin Test Request to FDA
January 16, 2013
In the News
Forbes: Oral Covid Vaccine Set To Begin Trials In Israel
August 30, 2021
In the News
Join our mailing list
Email
SUBSCRIBE
+1-844-9-ORAMED
office@oramed.com
Linkedin-in
Facebook-f
Twitter
Youtube
Home
About
Technology
Pipeline
Video Library
Contact us
NEWS
Press Releases
In the News
Scientific Articles and Abstracts
Events & Presentations
INVESTORS
Corporate presentation
Investor Relations
SEC filings
Investor FAQ
Governance documents
Annual shareholder meeting
Investor tools
Oravax Medical
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset
